Stay updated on Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision information updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check20 days agoChange DetectedNo additions or deletions detected; the page content and structure appear unchanged.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 as a metadata update; no study data or core content is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.1 is displayed, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedGlossary display is added and new data fields such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted are shown, while corresponding Estimated fields are removed and the site revision is updated to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo for Renal Cell Carcinoma Clinical Trial page.